title: [Catalytic autoantibodies--a new molecular instrument in cardiology and ophthalmology].
abstract: OBJECTIVE
  To develop a conceptual model of using catalytic autoantibodies as diagnostic and monitoring tools in organ-specific autoimmune disorders.
  
  
  METHODS
  A total of 99 patients (56 males and 43 females aged 21-52 years) with autoimmune myocarditis (AM) and 198 patients (77 males and 121 females aged 8-79 years) with autoimmune uveitis (A U) participated in the study. AM patients were examined for anticardiomyosin and anti-DNA autoantibodies (ACM, ADNAab), AU patients - for autoantibodies to S-antigen, IRBP, redopsin, phosphocine, autoDNA.
  
  
  RESULTS
  AM patients had double level of DNA-binding autoantibodies. In 1/3 of them there was hydrolysing DNA and cytotoxic activity. In AU patients maximal titers were in Behcet's disease, sympathic ophthalmia, generalized uveitis and viral uveitis.
  
  
  CONCLUSIONS
  Autoantibodies with different specificity and function including DNA-abzymes can be additional diagnostic and prognostic markers.
authors.forename: K A
authors.initials: KA
authors.lastname: Mal'tsev
authors.forename: A N
authors.initials: AN
authors.lastname: Khitrov
authors.forename: O Iu
authors.initials: OIu
authors.lastname: Vvedenskaia
authors.forename: N A
authors.initials: NA
authors.lastname: Ponomarenko
authors.forename: M A
authors.initials: MA
authors.lastname: Isaeva
authors.forename: M V
authors.initials: MV
authors.lastname: Klimova
authors.forename: E B
authors.initials: EB
authors.lastname: Tret'iak
authors.forename: Z S
authors.initials: ZS
authors.lastname: Shogenov
authors.forename: Z S
authors.initials: ZS
authors.lastname: Alekberova
authors.forename: S V
authors.initials: SV
authors.lastname: Gabibov
authors.forename: S V
authors.initials: SV
authors.lastname: Suchkov
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000097:blood; D017151:Antibodies, Catalytic / Q000097:blood*; D019393:Arrestin / Q000276:immunology; D001323:Autoantibodies / Q000097:blood*; D001327:Autoimmune Diseases / Q000175:diagnosis*; D015415:Biomarkers / Q000097:blood; D002648:Child; D004247:DNA / Q000276:immunology; D005136:Eye Proteins / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000175:diagnosis*; D009218:Myosins / Q000276:immunology; D011379:Prognosis; D012177:Retinol-Binding Proteins / Q000276:immunology; D012243:Rhodopsin / Q000276:immunology; D014605:Uveitis / Q000175:diagnosis*; D000099214:Retinol-Binding Proteins, Interstitial
chemical_list: D000974:Antibodies, Antinuclear; D017151:Antibodies, Catalytic; D019393:Arrestin; D001323:Autoantibodies; D015415:Biomarkers; D004247:DNA; D005136:Eye Proteins; D009218:Myosins; D012177:Retinol-Binding Proteins; D012243:Rhodopsin; D000099214:Retinol-Binding Proteins, Interstitial